147 related articles for article (PubMed ID: 37788104)
1. TSC2 S1365A mutation potently regulates CD8+ T cell function and differentiation and improves adoptive cellular cancer therapy.
Patel CH; Dong Y; Koleini N; Wang X; Dunkerly-Eyring BL; Wen J; Ranek MJ; Bartle LM; Henderson DB; Sagert J; Kass DA; Powell JD
JCI Insight; 2023 Nov; 8(21):. PubMed ID: 37788104
[TBL] [Abstract][Full Text] [Related]
2. MTORC1-Regulated Metabolism Controlled by TSC2 Limits Cardiac Reperfusion Injury.
Oeing CU; Jun S; Mishra S; Dunkerly-Eyring BL; Chen A; Grajeda MI; Tahir UA; Gerszten RE; Paolocci N; Ranek MJ; Kass DA
Circ Res; 2021 Mar; 128(5):639-651. PubMed ID: 33401933
[TBL] [Abstract][Full Text] [Related]
3. PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress.
Ranek MJ; Kokkonen-Simon KM; Chen A; Dunkerly-Eyring BL; Vera MP; Oeing CU; Patel CH; Nakamura T; Zhu G; Bedja D; Sasaki M; Holewinski RJ; Van Eyk JE; Powell JD; Lee DI; Kass DA
Nature; 2019 Feb; 566(7743):264-269. PubMed ID: 30700906
[TBL] [Abstract][Full Text] [Related]
4. PKG1α Cysteine-42 Redox State Controls mTORC1 Activation in Pathological Cardiac Hypertrophy.
Oeing CU; Nakamura T; Pan S; Mishra S; Dunkerly-Eyring BL; Kokkonen-Simon KM; Lin BL; Chen A; Zhu G; Bedja D; Lee DI; Kass DA; Ranek MJ
Circ Res; 2020 Jul; 127(4):522-533. PubMed ID: 32393148
[TBL] [Abstract][Full Text] [Related]
5. mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation.
Pollizzi KN; Patel CH; Sun IH; Oh MH; Waickman AT; Wen J; Delgoffe GM; Powell JD
J Clin Invest; 2015 May; 125(5):2090-108. PubMed ID: 25893604
[TBL] [Abstract][Full Text] [Related]
6. TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti-PD-1/anti-CTLA-4 immunotherapy.
Liu HJ; Lizotte PH; Du H; Speranza MC; Lam HC; Vaughan S; Alesi N; Wong KK; Freeman GJ; Sharpe AH; Henske EP
JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669930
[TBL] [Abstract][Full Text] [Related]
7. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
[TBL] [Abstract][Full Text] [Related]
8. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway.
Zhang HH; Huang J; Düvel K; Boback B; Wu S; Squillace RM; Wu CL; Manning BD
PLoS One; 2009 Jul; 4(7):e6189. PubMed ID: 19593385
[TBL] [Abstract][Full Text] [Related]
9. The E3 ubiquitin ligase Peli1 regulates the metabolic actions of mTORC1 to suppress antitumor T cell responses.
Ko CJ; Zhang L; Jie Z; Zhu L; Zhou X; Xie X; Gao T; Yang JY; Cheng X; Sun SC
EMBO J; 2021 Jan; 40(2):e104532. PubMed ID: 33215753
[TBL] [Abstract][Full Text] [Related]
10. DAPK1 (death associated protein kinase 1) mediates mTORC1 activation and antiviral activities in CD8
Wei Z; Li P; He R; Liu H; Liu N; Xia Y; Bi G; Du Q; Xia M; Pei L; Wang J; Wang G; Tang ZH; Cheng X; Li H; Li Z; Ye L; Laurence A; Lu Y; Yang XP
Cell Mol Immunol; 2021 Jan; 18(1):138-149. PubMed ID: 31541182
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of 6-phosphofructo-2-kinase (PFKFB3) by hyperactivated mammalian target of rapamycin complex 1 is critical for tumor growth in tuberous sclerosis complex.
Wang Y; Tang S; Wu Y; Wan X; Zhou M; Li H; Zha X
IUBMB Life; 2020 May; 72(5):965-977. PubMed ID: 31958214
[TBL] [Abstract][Full Text] [Related]
12. Tsc1 promotes the differentiation of memory CD8+ T cells via orchestrating the transcriptional and metabolic programs.
Shrestha S; Yang K; Wei J; Karmaus PW; Neale G; Chi H
Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14858-63. PubMed ID: 25271321
[TBL] [Abstract][Full Text] [Related]
13. Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells.
Chen W; Pan Y; Wang S; Liu Y; Chen G; Zhou L; Ni W; Wang A; Lu Y
BMC Cancer; 2017 Jan; 17(1):34. PubMed ID: 28061838
[TBL] [Abstract][Full Text] [Related]
14. IL-36β Promotes CD8
Zhao X; Chen X; Shen X; Tang P; Chen C; Zhu Q; Li M; Xia R; Yang X; Feng C; Zhu X; Zhu Y; Sun Z; Zhang X; Lu B; Wang X
Front Immunol; 2019; 10():1803. PubMed ID: 31447838
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of TSC2 by PKC-δ reveals a novel signaling pathway that couples protein synthesis to mTORC1 activity.
Zhan J; Chitta RK; Harwood FC; Grosveld GC
Mol Cell Biochem; 2019 Jun; 456(1-2):123-134. PubMed ID: 30684133
[TBL] [Abstract][Full Text] [Related]
16. Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity.
Berezhnoy A; Castro I; Levay A; Malek TR; Gilboa E
J Clin Invest; 2014 Jan; 124(1):188-97. PubMed ID: 24292708
[TBL] [Abstract][Full Text] [Related]
17. mTORC1 Activity in Psoriatic Lesions Is Mediated by Aberrant Regulation through the Tuberous Sclerosis Complex.
Ferreri A; Lang V; Kaufmann R; Buerger C
Cells; 2022 Sep; 11(18):. PubMed ID: 36139422
[TBL] [Abstract][Full Text] [Related]
18. A new homozygous HERC1 gain-of-function variant in MDFPMR syndrome leads to mTORC1 hyperactivation and reduced autophagy during cell catabolism.
Schwarz JM; Pedrazza L; Stenzel W; Rosa JL; Schuelke M; Straussberg R
Mol Genet Metab; 2020; 131(1-2):126-134. PubMed ID: 32921582
[TBL] [Abstract][Full Text] [Related]
19. Role of tumor suppressor TSC1 in regulating antigen-specific primary and memory CD8 T cell responses to bacterial infection.
Krishna S; Yang J; Wang H; Qiu Y; Zhong XP
Infect Immun; 2014 Jul; 82(7):3045-57. PubMed ID: 24818661
[TBL] [Abstract][Full Text] [Related]
20. Tuberous sclerosis-2 (TSC2) regulates the stability of death-associated protein kinase-1 (DAPK) through a lysosome-dependent degradation pathway.
Lin Y; Henderson P; Pettersson S; Satsangi J; Hupp T; Stevens C
FEBS J; 2011 Jan; 278(2):354-70. PubMed ID: 21134130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]